Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMBISOME vs AMBRISENTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMBISOME vs AMBRISENTAN: Safety Overview

Metric AMBISOME AMBRISENTAN
Total FAERS Reports 120 86,197
Deaths Reported 69 10,291
Death Rate 57.5% 11.9%
Hospitalizations 27 32,910
Average Patient Age 45.6 yrs 59.5 yrs
% Female Patients N/A 76.1%
FDA Approval Date N/A Apr 10, 2019
Manufacturer N/A Sigmapharm Laboratories, LLC
Route N/A ORAL
Marketing Status N/A Prescription